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Abstract
We assessed the validity of the pressure^time index (PTI) measured at themouth as a noninvasive and simplified alter-
native to conventional tension^time index for assessing respiratory load and inspiratorymuscle force reserve. PTI was
measuredwithin 48 h of hospital admission and at 24 h before discharge in 37 consecutive patientswith acute exacerba-
tion of chronic obstructive pulmonarydisease(COPD) using the equation PTI = (Pawo/MIP)(TI/TT)100, where Pawo is the
mean airwaypressuremeasured atthemouth,MIP themaximalinspiratorypressure, and TI/TT the inspiratory time (TI)
to total cycle length (TT) ratio.Controlswere 30 normalvolunteerswith similar anthropometric features.Mean (7 SD)
PTI values were significantly higher in COPD patients (0.297 0.10) than in controls (0.117 0.04) (Po0.001) primarily
because MIP and TI/TTwere significantly lower and Pawowashigher inthe COPD populationthan in controls. As a result
of improvement of the respiratory condition, PTI values were significantly lower at discharge (0.2070.10 vs. 0.2970.10,
Po0.001) dueto adropin Pawo andanincreaseinMIP.The accuracyofdifferent PTIcutpointswas assessedbycomparison
ofthereceiveroperatingcharacteristics curves.Bestcutpoint values fordifferentiating COPD patients on admission and
at hospital discharge from controls were 0.13 (positive predictive value 76%) and 0.17 (positive predictive value 92%),
respectively.Noninvasive PTImeasured atthemouth provides a valid and easymethod for assessing respiratorymuscle
load and reserve.Changes in PTI values reflect functional improvement following treatment of acute exacerbation of
COPD.r2003 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1464, available online at http://www.sciencedirect.com
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Respiratory muscle fatigue, especially that of the dia-
phragm, is de¢ned as the inabilityof amuscle to continue
to generate a given tension. In healthy persons, inspira-
tory muscle fatigue occurs only under extreme condi-
tions, such as experimental respiratory loading (1) or
highly demanding strenuous exercise. By contrast, in-Correspondence shouldbe addressed to :Dr J.Marin,Departamento de
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2002spiratory muscles of patients with chronic obstruc-
tive pulmonary disease (COPD) may be functioning
close to the tension threshold of fatigue, so that
small departures from the spontaneous breathing
pattern (e.g., episodes of acute exacerbation) can lead
to respiratory failure (2^4). During an acute exacerba-
tion, theCOPDpatients are atriskof developing respira-
tory fatigue because their inspiratory muscle force
reserve is smaller than in normal subjects. Therefore,
accurate and prompt detection of increased load
to the inspiratory muscles could be very useful in
the identi¢cation and control of subclinical respiratory
failure.
416 RESPIRATORYMEDICINEIt has been shown that respiratory muscles reach
a fatiguing level when the product of the e¡ort they
generate and the duration of their contraction exceed
a critical threshold. The tension^time index of the
diaphragm (TTdi) proposed by Bellemare and Grassino
(5,6) can be used to predict the onset of diaphrag-
matic fatigue. It is calculated as the product of the
pressure generated by the diaphragm during tidal
breathing (Pdi) expressed as a fraction of the
maximal force that the diaphragm can generate (Pdimax ),
and the duration of the muscle contraction expressed
as the ratio of inspiratory time (TI) to total cycle dura-
tion (TT), with the following equation: TTdi = (Pdi/
Pdimax )(TI/TT).
Measurement of TTdi, however, has mostly been used
for research protocols in the laboratory setting because
therequirementof a ballooncatheter system tomeasure
esophageal and gastric pressures has limited its applica-
tion in clinical practice. In the studies of Bellemare and
Grassino (5,6),TTdiwas establishedusing the transdiaph-
ragmatic pressure (Pdi) as an expression of the e¡ort
for each ventilatory cycle and Pdimax as an expression of
the maximal e¡ort capacity. However, a simpli¢ed
noninvasive index can be obtained with the use of the
pressure measured at the mouth with the open airway
(Pawo) as an alternative to Pdi and themaximal inspiratory
pressure (MIP) instead of Pdimax.Thus, the pressure^time
index (PTI) is derived from the equation, PTI = (Pawo/
MIP)(TI/TT). As the mouth pressure that can be devel-
oped against an occluded airway at conditions of con-
traction in healthy subjects is much greater than the
pressure that can be developed under conditions of
shortening against the elastic and resistive forces seen
during acute exacerbation of the COPD, to overcome
this di⁄culty thepressure is best referenced to themax-
imum pressure (MIP) that can be generated under the
same conditions of contraction. In a previous study of
noninvasive nasalmask ventilation in the treatment of15
patientswith exacerbation of chronic respiratory insu⁄-
ciency (7), clinical andbloodgas exchange improvements
were associatedwith statistically signi¢cantdecreases of
PTI in a subgroup of six patients in whom parameters
of ventilatory muscle function and respiratory drive
were measured. In accordance with these preliminary
results, another study carried out in a small group of
COPD patients showed that PTI measured at the
mouth adequately re£ected diaphragmatic TTdi and its
electromyographic signal analysis at rest and during a
CO2 rebreathing (8).
To validate the feasibility of PTI in clinical practice, a
prospective study was designed with the following pur-
poses: (a) to assess PTI values in patients admitted to the
hospital for an episode of acute exacerbation of COPD,
(b) to compare PTI values obtainedwithin 48h of admis-
sion and at 24h before discharge from the hospital, and
(c) to determine PTI values in a group of normal volun-teers with similar age and anthropometric characteris-
tics than patients with COPD.
METHODS
The study population included 37 patients admitted con-
secutively to the respiratory ward of our hospital for
treatment of an acute exacerbation episode of COPD.
All patients had COPD con¢rmed by medical history,
clinical and functional examinations and ful¢lled the cri-
teria of the AmericanThoracic Society for acute exacer-
bation (9).The control group consisted of 30 volunteers
seen at the respiratory function laboratory for routine
preoperative assessment. They had no history of pul-
monary disease or respiratory symptoms, and had nor-
mal spirometry. In order to study homogeneous samples
of both COPD patients and controls, only subjects older
than 60 years of age were included. The study protocol
was approved by the institutional review board and all
participants gave their written informed consent.
Physiologicmeasurements
PatientswithCOPDwere studiedon two separate occa-
sions, that is, within 48h of admission to the hospital and
at 24hbefore discharge. In each case, decisions regarding
hospital admission and discharge were taken by the phy-
sician in charge of the patient who was unaware of the
purpose and results of the study. All patients were trea-
ted according to the same conventional treatment for
COPD patients not requiring ICU admission. Subjects in
the control group were studied once. Forced vital capa-
city (FVC), forced expiratory volume in 1s (FEV1), and
£ow^volume curves were obtained using a calibrated
pneumotachograph (Micro S-2000, C. Schatzman, Ma-
drid, Spain). Aminimumof three air£ow and volume tra-
cings was obtained and the highest value for FVC and
FEV1as percent predicted normal were used for calcula-
tions.
Ventilatory parameters were obtained using a Lilly-
type pneumotachograph connected to a Mingograf re-
corder (Siemens, Elema,Germany). Inspiratory time (TI)
and total duration of breathing cycle (TT) (TI/TT) were
measured, separating the inspiratory line from the ex-
piratory one by return of the volume signal to resting le-
vels at point zero air£ow. The mean airway pressure
measured at themouth (Pawo) was assessed on the pres-
sure signal curve, during spontaneous breathing and
after regular ventilation patternwas obtained.The pres-
sure signal was recorded for 15min at a paper speed of
6 cm/min.Themean airway pressurewas then calculated
by summing the pressure values of sequential millise-
conds intervals and expressed as the mean value of all
breaths taken over the whole interval. MIP was deter-
mined using an electromanometer with a transducer
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ge,7300 cm H2O; resolution, 1cm H2O) (10). The sub-
ject was asked to do a maximal inspiratory e¡ort
against a partially occluded airway and to maintain max-
imal pressure forZ1s.MIP was determined at near-resi-
dual volume as the best of three maximum inspiratory
maneuvers in which intratesting di¡erences were less
than10%. Results were compared with predicted values
reported by Black and Hyatt (11). Both pressures were
calculatedwith sign as negative.
PTI was derived from the following equation: PTI =
(Pawo/MIP)(TI/TT).The resultwasmultipliedby100 to sim-
plify calculations.
Arterial blood gases were measured at rest while
breathing room air (Radiometer ABL 500, Radiometer,
Copenhagen, Denmark). Blood samples were analyzed
for arterial carbon dioxide tension (PaCO2), arterial oxy-
gen tension (PaO2), and pH.
Statistical analysis
Data are expressed as mean (7 SD). Results obtained in
COPD patients and in controls were comparedwith the
Student’s t-test for independent samples,whereas results
atdi¡erent times in patientswithCOPDwere compared
with the t-test for paired samples. Statistical signi¢cance
was set at Po0.05. The discriminatory ability of PTI
scores for di¡erentiating COPD patients from controls
was evaluated using the receiver operating characteris-
tics (ROC) curves (12).
RESULTS
As shown inTable1, therewere no di¡erences in anthro-
pometric characteristics between COPD patients and
the controls. However, results of pulmonary functionTABLE 1. Anthropometricdata, pulmonary functiontests, and
COPD p
At admission
Age (years) 70.677.7
Weight (kg) 73.2712.2
Height (cm) 16476
FEV1 (% predictednormal) 31.978.6
FVC (% predictednormal) 50.3713.7
FEV1/FVC 0.4970.09
PaO2 (mmHg) 50.679.2
PaCO2 (mmHg) 52.8711.7
PH 7.4070.03
Data asmean7 SD.
*Po0.001between COPDat admission and controls.
**Po0.001between COPDat admission and atdischarge.tests were signi¢cantly di¡erent between both groups
and revealed severe air£ow limitation with hypoxemia
and hypercapnia in patients with COPD.
Breathing cycle parameters in COPD patients and
controls are detailed in Table 2. Measurements taken
within 48h of admission to the hospital showed for pa-
tients with COPD numerically greater values for Pawo
and reduced magnitude of MIP, which were signi¢cantly
di¡erent than those found in controls (Po0.001).TheTI/
TTratio was signi¢cantly lower in patients than in con-
trols (0.3770.05 vs. 0.4170.05, Po0.001). Accordingly,
COPD patients had a signi¢cantly higher PTI values than
controls (0.297 0.10 vs 0.117 0.04,Po0.001). Appropri-
ate treatment of the acute exacerbation episode of
COPD resulted in a statistically signi¢cant decrease of
the initial mean PTI value to 0.20 7 0.10 (Po0.001),
although this value was still signi¢cantly higher than in
controls.Table 3 shows thevalues of PTIwithin the group
of the patients.
To determine if the relative value of the PTImeasured
on admissionwouldpredict anythingwith regard to clini-
cally coursewhilehospitalizedwehave done a logistic re-
gression with the value of the PTI at admission and
another variables as FEV1, PaCO2 and PaO2 but the re-
sults were negative.
Di¡erences of PTI values between COPD patients on
admission and controls showed that a PTI threshold va-
lue of 0.17 had a 90% sensitivity and speci¢city and a 92%
positive predictive value for di¡erentiating acutely
decompensated COPD patients from controls. The
threshold value at which PTI di¡erentiated patients at
hospital discharge with improved respiratory condition
fromcontrols was 0.13.This cutpoint showed a sensitivity
of 78%, speci¢city of 70%, and positive predictive value
of 76%.
The threshold value atwhich PTI di¡erentiatedwithin
COPD patients from admission to discharge was 0.22.bloodgases inthe studypopulation.
atients, (n=37) CONTROLS, n=30
Atdischarge
70.377.6 66.477.4
73.6712.6 70.0712.7
1647 6 16177
41.2715.5** 112.1720.7*
62.07713.6** 111.4716.1*
50.6711.0 0.8370.05*
60.6711.4** 85.178.5*
50.3479.3 39.475.0
7.4270.03** 7.4270.05
TABLE 2. Breathingcycle parameters in COPD patients and controls
COPD patients, (n=37) CONTROLS, n=30
Parameters On admission Before discharge
Pawo (cmH2O) -0.4170.09 -0.3470.10
** -0.2170.05*
MIP (cmH2O) -55.1715.8 -70.2724.4
** -84.5721.7*
Pawo/MIP 0.00970.01 0.00870.01 0.00270.001
*
TI/TT 0.3770.05 0.3870.05 0.4170.05
*
PTI 0.2970.10 0.2070.10** 0.1170.04*
Pawo, mouth pressurewith open airwayduring tidal breathing;MIP, maximal inspiratorypressure;TI/TT, inspiratory time (TI)
to total duration of breathingcycle (TT) ratio;PTI, pressure^time index.Data asmean7SD
*Po0.001between COPDat admission andnormal subjects.
**Po0.001between COPDat admission andbefore discharge.
TABLE 3. PTIvalueswithinthe group ofthe patients.
PTI
COPD At admission Atdischarge
1 0.19 0.14
2 0.38 0.14
3 0.32 0.14
4 0.36 0.34
5 0.40 0.27
6 0.30 0.26
7 0.28 0.16
8 0.25 0.16
9 0.12 0.44
10 0.28 0.19
11 0.20 0.14
12 0.25 0.14
13 0.26 0.23
14 0.58 0.20
15 0.15 0.13
16 0.26 0.30
17 0.36 0.24
18 0.19 0.12
19 0.33 0.16
20 0.39 0.26
21 0.21 0.17
22 0.13 0.09
23 0.38 0.11
24 0.18 0.23
25 0.50 0.50
26 0.34 0.17
27 0.22 0.19
28 0.27 0.21
29 0.21 0.18
30 0.16 0.10
31 0.45 0.11
32 0.25 0.12
33 0.24 0.18
34 0.18 0.15
35 0.46 0.36
36 0.36 0.30
37 0.28 0.07
418 RESPIRATORYMEDICINEThis cutpoint showed a sensitivity of 65%, speci¢city of
70% and positive predictive value of 71%.
The ¢ndings obtained with the current method have
been comparedwith those of more traditional examina-
tions such as FEV1, PaCO2 and PaO2Fboth with regard
to di¡erence and di¡erentiation between patients and
controls and for improvement from admission to dis-
charge. Comparisons have been made with the ROC
curves and the results are depicted in Figs.1^3.
DISCUSSION
Important ¢ndings of the present study are as follows:
¢rstly, that a simple noninvasive PTI measured at the
mouth is signi¢cantly higher in patients with COPD than
in controls, and secondly, that improvement of the pa-
tient’s condition as a result of treatment of acute exacer-
bation was associated with decreases in PTI values.
However, PTI levels in COPD patients with improved
clinical condition, that is, at hospital discharge, remained
signi¢cantly higher than the corresponding values in nor-
mal volunteers.
Assessing the magnitude of the fatiguing process of
the respiratorymuscles or their response to mechanical
load has been an important but di⁄cult goal in clinical
practice. Several indices have been used to provide such
information. The best characterized of these diagnostic
tools is theTTdi, although it is relatively speci¢c for the
functional assessment of the diaphragm. Normal value
for adults is 0.0270.01. Under experimental conditions,
if the index increases beyond a critical value of 0.15^0.20
(threshold zone of fatigue), contraction of the diaphragm
can only be sustained for approximately1h (time limit or
Tlim) (5). TheTTdi has not gained widespread clinical ac-
ceptance because it is relatively invasive and its thresh-
olds can only be determined under strict experimental
conditions.
In other studies inwhichnoninvasive assessmentof re-
spiratorymuscles load was determined, themean age of
the study groups were di¡erent, so that results may be
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PTI      area=0.75±0.05
PO2     area=0.75±0.05
FEV1  area=0.69±0.05
PCO2  area=0.53±0.06
FIG. 1 Receiver operating characteristics (ROC) curves for
PTI measured at the mouth, FEV1, PaO2 and PaCO2 within pa-
tients from admission to discharge. Areas under the curve
7SDof each index are given.
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sign of the present study included recruitment of two
matched groups in terms of age and anthropometric
characteristics. We sought homogeneity in the groups
because it iswell known that there is a loss of pulmonary
function as well as of muscle strength and muscle mass
with aging (11).
The simple and noninvasive PTI measured at the
mouth, as herereported, aims to be a practical and com-
prehensive measurement of the e¡ort to breathe and
may be an overall measure of the load placed on the re-
spiratory muscles.The index is measured while the sub-
ject breathes spontaneously, requires minimal
cooperation on the part of the subject, and is highly re-
producible.The information providedby the PTI is di¡er-
ent from that o¡ered by the TTdi, because not only
diaphragmatic e¡ort is measured, but also the contribu-
tion of inspiratory muscles acting in concert (8). In this
way, the major determining factors to induce muscle fa-
tigue are the magnitude of the pressure used to breathe
(heremeasured as the Pawo) and its relationshipwithMIP.
This relationship shows the balance between the magni-
tude of the respiratory load and the muscle strength
available to confront it (4). Inmostpatients,PTI increases
(or the onset of fatigue would be accelerated) in situa-
tions in which the Pawo increases (e.g., with an increase
in the resistance of the airway or a decrease in compli-
ance) or conversely, in patients whose MIP decreases
(e.g., muscle weakness or mechanical deterioration),
which occurs as the obstruction to air£ow worsens (14).
On admission to the hospital, COPD patients had a
meanTI/TTvalue of 0.3770.05.This was signi¢cantly low-
er than that found in normalvolunteers (0.417 0.05) and
in agreement with the values reported byTobin et al. (15)
but substantially lower than 0.4970.10 describedby Bel-
lemare and Grassino (6) in the experimental conditions
of their study.Our ¢ndings suggest that changes inTI/TT
are relatively small and occur in the direction of decreas-
ing the PTI. In addition,TTdi depends on the Pdi/Pdimax and
TI/TT, while the spontaneous PTI is less in£uencedby the
TI/TT. Indeed, the correlationbetween Pawo/MIP and TI/TT
was poor (r = 0.2).
As shown in our preliminary results, PTI decreases
after mechanical improvement in patients with an ex-
acerbation of chronic respiratory insu⁄ciency (7). In the
present study, higher PTI values at the time of patient’s
admission to the hospital were found to have decreased
signi¢cantly at the time of discharge.PTI improved as the
magnitude of the load decreased (mainly seen as a fall in
Pawo) in a similar degree than in our previous study, 0.7 vs.
0.8. Simultaneously, as functional parameters of the
COPD acute exacerbation episode improved, there was
an increase in MIP probably as a consequence of a de-
crease in dynamic hyperin£ation. The combination of
both changeswould account for the signi¢cant improve-
ment in PTI.When we showed the changes of PTI within the pa-
tients (Table 3), we observed that there were three pa-
tients for whom the value of the index between
admission and discharge rose; they are the patients 9, 16
and 24.Of these, patient 9 admitted again to the hospital
10 days after the dischargewhile patient16was admitted
to the ICU14 days after the discharge.
When comparing the results obtained with the cur-
rent method with those of more traditional examina-
tions such as FEV1, PaCO2 and PaO2Fboth with regard
to di¡erence and di¡erentiation between patients and
controls and for improvement from admission to dis-
charge, the results showed that for di¡erenceswithin pa-
tients, the PTIwas close to PaO2, with an area under the
curve of 0.7570.05 and presented better discriminatory
power than FEV1and PaCO2 (Fig.1).
With respect to the di¡erentiation between patients
and controls, the PTI did atdischarge showagreater area
under theROCcurve (0.8070.06) than PaO2 and PaCO2
(0.5470.06 and 0.7770.05, respectively) while on ad-
mission it showed a smaller area than FEV1 and PaO2
(Figs. 2 and 3).
In summary, PTI measured at the mouth during spon-
taneousbreathing is a useful, noninvasive, and reproduci-
ble measurement of overall respiratory load, which
provides important information regarding mechanical
load and functional reserve of the respiratory muscles.
Variations in PTI values re£ect clinical changes experi-
enced by COPD patients during episodes of acute ex-
acerbation and can be used as a complementary tool to
clinical and laboratory data for establishing the degree of
respiratory impairment.
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FIG. 2 ROCcurves for PTImeasuredatthemouth,FEV1,PaO2
and PaCO2 between patients at admission and controls. Areas
under the curve7SD of each index are given
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